Navin K Chintala

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Transforming Growth Factor

Top Venues

Journal for immunotherapy of cancer

Nature protocols

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

David Restle, Joseph Dux, Xiaoyu Li, Alexander J Byun, Jennie K Choe, Yan Li, Raj G Vaghjiani, Carlos Thomas, Kyohei Misawa, Kay See Tan, David R Jones, Navin K Chintala, Prasad S Adusumilli
Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma. Journal for immunotherapy of cancer 11 (6) (2023)
Hue Tu Quach, Matthew S Skovgard, Jonathan Villena-Vargas, Rebecca Y Bellis, Navin K Chintala, Alfredo Amador-Molina, Yang Bai, Srijita Banerjee, Jasmeen Saini, Yuquan Xiong, William-Ray Vista, Alexander J Byun, Andreas R de Biasi, Masha Zeltsman, Marissa Mayor, Aurore Morello, Vivek Mittal, Daniel R Gomez, Andreas Rimner, David R Jones, Prasad S Adusumilli
Tumor-targeted non-ablative radiation promotes solid tumor CAR T-cell therapy efficacy. Cancer immunology research (2023)
Yuquan Xiong, Meriem Taleb, Kyohei Misawa, Zhaohua Hou, Srijita Banerjee, Alfredo Amador-Molina, David R Jones, Navin K Chintala, Prasad S Adusumilli
c-Kit signaling potentiates CAR T cell efficacy in solid tumors by CD28- and IL-2-independent co-stimulation. Nature cancer (2023)
David Restle, Joseph Dux, Xiaoyu Li, Alexander J Byun, Jennie K Choe, Yan Li, Raj G Vaghjiani, Carlos Thomas, Kyohei Misawa, Kay See Tan, David R Jones, Navin K Chintala, Prasad S Adusumilli
Organ-specific heterogeneity in tumor-infiltrating immune cells and cancer antigen expression in primary and autologous metastatic lung adenocarcinoma. Journal for immunotherapy of cancer 11 (6) (2023)
Prasad S Adusumilli, Marjorie G Zauderer, Isabelle Rivière, Stephen B Solomon, Valerie W Rusch, Roisin E O'Cearbhaill, Amy Zhu, Waseem Cheema, Navin K Chintala, Elizabeth Halton, John Pineda, Rocio Perez-Johnston, Kay See Tan, Bobby Daly, Jose A Araujo Filho, Daniel Ngai, Erin McGee, Alain Vincent, Claudia Diamonte, Jennifer L Sauter, Shanu Modi, Devanjan Sikder, Brigitte Senechal, Xiuyan Wang, William D Travis, Mithat Gönen, Charles M Rudin, Renier J Brentjens, David R Jones, Michel Sadelain
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti-PD-1 Agent Pembrolizumab. Cancer discovery 11 (11) (2021)
Stefan Kiesgen, John C Messinger, Navin K Chintala, Zachary Tano, Prasad S Adusumilli
Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity. Nature protocols 16 (3) (2021)